Search

Your search keyword '"Amadou Niangaly"' showing total 85 results

Search Constraints

Start Over You searched for: Author "Amadou Niangaly" Remove constraint Author: "Amadou Niangaly"
Sorry, I don't understand your search. ×
85 results on '"Amadou Niangaly"'

Search Results

1. Immune gene expression changes more during a malaria transmission season than between consecutive seasons

2. Gene expression analyses reveal differences in children’s response to malaria according to their age

Catalog

Books, media, physical & digital resources

3. Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1s

4. Immunogenomic profile at baseline predicts host susceptibility to clinical malaria

5. Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles.

6. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial

7. Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation

8. Successful Profiling of Plasmodium falciparum var Gene Expression in Clinical Samples via a Custom Capture Array

9. Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag

10. An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes

11. Host and Parasite Transcriptomic Changes upon Successive Plasmodium falciparum Infections in Early Childhood

12. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A

13. New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali

14. Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure

15. Genetic polymorphisms with erythrocyte traits in malaria endemic areas of Mali.

16. Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.

17. Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia

18. Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.

19. Candidate polymorphisms and severe malaria in a Malian population.

20. Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.

21. Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.

22. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial

23. Ex Vivo Plasmodium malariae Culture Method for Antimalarial Drugs Screen in the Field

24. Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles

25. Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation

26. A Decline and Age Shift in Malaria Incidence in Rural Mali following Implementation of Seasonal Malaria Chemoprevention and Indoor Residual Spraying

27. The estimated burden of fungal diseases in Mali

28. IFNγ, TNFα polymorphisms and IFNγ serum levels are associated with the clearance of drug-resistant P. falciparum in Malian children

29. Successful Profiling of Plasmodium falciparum var Gene Expression in Clinical Samples via a Custom Capture Array

30. Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag

31. Spatio-temporal distribution of malaria one year after the implementation of additional preventive strategies in Bandiagara, Mali

32. Host and Parasite Transcriptomic Changes upon Successive Plasmodium falciparum Infections in Early Childhood

33. Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02(A) vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants

34. A decline and age shift in malaria incidence in rural Mali following implementation of seasonal malaria chemoprevention and indoor residual spraying

35. Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination

36. Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?

37. Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets

38. The Pan African Vivax and Ovale Network (PAVON): Refocusing on Plasmodium vivax, ovale and asymptomatic malaria in sub-Saharan Africa

39. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial

40. New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali

41. Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure

42. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A

43. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate

44. Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children

45. Seroreactivity to a Large Panel of Field-Derived Plasmodium falciparum Apical Membrane Antigen 1 and Merozoite Surface Protein 1 Variants Reflects Seasonal and Lifetime Acquired Responses to Malaria

46. Differential Recognition of Terminal Extracellular Plasmodium falciparum VAR2CSA Domains by Sera from Multigravid, Malaria-Exposed Malian Women

47. Spatio-temporal dynamics of asymptomatic malaria : bridging the gap between annual malaria resurgences in a Sahelian environment

48. Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, Mali

49. Reappraisal of known malaria resistance loci in a large multicenter study

50. Additional file 2: of New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali